Ovoca Bio is developing a new treatment for women affected by low libido or sex drive and is recruiting volunteers for a new clincial study to test it.
This trial is being conducted in Australia and New Zealand and is registered with the ANZCTR, which is an online public registry of clinical trials held at the NHMRC Clinical Trials Center, University of Sydney. The registration can be viewed through the following link: ACTRN12620001356954
New Study: A Potential Treatment for Women Concerned about Low Libido
What is low libido or low sex drive?
Libido, also known as your sex drive, can vary from woman to woman and there is no right or wrong level. Many women will experience low libido at some time in their lives. Low libido can include absence of sexual thoughts or fantasies, loss of desire for, or interest in sexual activity and loss of response to a partner initiating sexual activity. For many women this can cause anxiety, frustration, guilt or sadness. A medical term hypoactive sexual desire disorder/ dysfunction (HSDD) is used when women experience loss of sexual desire that causes them personal distress. HSDD can only be diagnosed after other factors such as depression, relationship issues and discomfort with sex have been excluded.
What is the study about?
This study is exploring a new nasal spray as a potential treatment for women with low libido or low sex drive that causes them personal distress (HSDD). The aim of the study is to measure the effect of three different doses administered daily, compared to placebo on sexual desire levels in women with low libido or HSDD. The study is also evaluating the treatment’s effect on the degree to which low libido or low sex drive bothers participants taking part in the study.
Where can I find out more or apply?
More information about the study and to find out if you are eligible to participate can be found by clicking on the Register button below.